ES2117390T3 - Sales de un acido graso poliinsaturado y formulaciones farmaceuticas que las contienen. - Google Patents
Sales de un acido graso poliinsaturado y formulaciones farmaceuticas que las contienen.Info
- Publication number
- ES2117390T3 ES2117390T3 ES95903298T ES95903298T ES2117390T3 ES 2117390 T3 ES2117390 T3 ES 2117390T3 ES 95903298 T ES95903298 T ES 95903298T ES 95903298 T ES95903298 T ES 95903298T ES 2117390 T3 ES2117390 T3 ES 2117390T3
- Authority
- ES
- Spain
- Prior art keywords
- salts
- fatty acid
- pharmaceutical formulations
- formulations containing
- polyinsaturated fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
SALES DE ACIDO 4,7,10,13,16,19 - CIS - DOCOSAHEXAENOICO (DHA) CON AMINOACIDOS BASICOS, EN PARTICULAR ARGININA Y LISINA, TIENEN CARACTERISTICAS TERAPEUTICAS Y TECNOLOGICAS FAVORABLES (SOLUBILIDAD EN AGUA) COMPARADAS CON EL ACIDO DE INICIO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT93MI002612A IT1264987B1 (it) | 1993-12-14 | 1993-12-14 | Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2117390T3 true ES2117390T3 (es) | 1998-08-01 |
Family
ID=11367322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95903298T Expired - Lifetime ES2117390T3 (es) | 1993-12-14 | 1994-11-28 | Sales de un acido graso poliinsaturado y formulaciones farmaceuticas que las contienen. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5750572A (es) |
EP (1) | EP0734373B1 (es) |
JP (1) | JPH09508619A (es) |
AU (1) | AU1241295A (es) |
DE (1) | DE69409969T2 (es) |
ES (1) | ES2117390T3 (es) |
IT (1) | IT1264987B1 (es) |
WO (1) | WO1995016661A1 (es) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107499A (en) * | 1988-02-26 | 2000-08-22 | Neuromedica, Inc. | Dopamine analog amide |
AUPM906594A0 (en) * | 1994-10-26 | 1994-11-17 | Peptide Technology Limited | Synthetic polyunsaturated fatty acid analogues |
US5795909A (en) * | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US6576636B2 (en) * | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
US5955459A (en) * | 1997-11-26 | 1999-09-21 | Neuromedica, Inc. | Fatty acid-antipsychotic compositions and uses thereof |
US6197764B1 (en) | 1997-11-26 | 2001-03-06 | Protarga, Inc. | Clozapine compositions and uses thereof |
FR2781371B1 (fr) * | 1998-07-21 | 2001-04-27 | Oreal | Composition cosmetique aqueuse transparente a une seule phase |
US7235583B1 (en) * | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
AU2002303164A1 (en) | 2001-03-23 | 2002-10-08 | Protarga, Inc. | Fatty amine drug conjugates |
ES2387562T3 (es) * | 2001-03-23 | 2012-09-26 | Luitpold Pharmaceuticals, Inc. | Conjugados alcohol graso-medicamento |
GB0210212D0 (en) * | 2002-05-03 | 2002-06-12 | Univ Southampton | Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability |
US8729124B2 (en) | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
JP2003261456A (ja) * | 2002-03-08 | 2003-09-16 | Howaizu:Kk | 脳の老化予防剤 |
US7935365B2 (en) | 2003-10-22 | 2011-05-03 | Enzymotec, Ltd. | Glycerophospholipids for the improvement of cognitive functions |
US20050130937A1 (en) * | 2003-10-22 | 2005-06-16 | Enzymotec Ltd. | Lipids containing omega-3 and omega-6 fatty acids |
US8052992B2 (en) * | 2003-10-22 | 2011-11-08 | Enzymotec Ltd. | Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions |
HU227588B1 (hu) * | 2004-12-03 | 2011-09-28 | Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft | Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény |
ITMI20072142A1 (it) * | 2007-11-08 | 2009-05-09 | Yervant Zarmanian | Composizioni farmaceutiche contenenti statine e derivati di acidi grassi omega-3 |
CN105267969A (zh) * | 2008-01-04 | 2016-01-27 | 雀巢产品技术援助有限公司 | 包含不饱和脂肪酸和一氧化氮释放化合物的组合物及其用于增强认知和相关功能的用途 |
CN102316865B (zh) | 2008-12-12 | 2017-04-19 | 科耐特有限公司 | 用于改善正常的认知功能的l‑赖氨酸 |
UA114615C2 (uk) | 2012-01-06 | 2017-07-10 | Омтера Фармасьютікалз, Інк. | Збагачена дпк композиція омега-3 поліненасичених жирних кислот у формі вільної кислоти |
US9999626B2 (en) * | 2014-06-18 | 2018-06-19 | Thetis Pharmaceuticals Llc | Mineral amino-acid complexes of active agents |
RU2706072C2 (ru) * | 2014-12-23 | 2019-11-13 | Эвоник Дегусса Гмбх | Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты |
SG11201704396XA (en) * | 2014-12-23 | 2017-07-28 | Evonik Degussa Gmbh | Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids |
FR3031451B1 (fr) * | 2015-01-13 | 2018-03-23 | Greentech | Sel d'un triglyceride, preparation et utilisations |
AU2017270134B2 (en) * | 2016-05-25 | 2022-09-01 | Evonik Operations Gmbh | Tablets with high active ingredient content of omega-3 fatty acid amino acid salts |
EP3248467A1 (de) * | 2016-05-25 | 2017-11-29 | Evonik Technochemie GmbH | Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze |
EP3454907B1 (en) | 2016-06-03 | 2020-07-22 | Thetis Pharmaceuticals LLC | Compositions and methods relating to salts of specialized pro-resolving mediators of inflammation |
WO2019008101A1 (en) | 2017-07-06 | 2019-01-10 | Evonik Technochemie Gmbh | ENTERICALLY COATED SOLID DOSAGE FORM COMPRISING AMINO ACIDS SALTS OF OMEGA-3 FATTY ACIDS |
WO2019034698A1 (en) | 2017-08-15 | 2019-02-21 | Evonik Technochemie Gmbh | TABLET WITH HIGH ACTIVE INGREDIENT CONTENT OF OMEGA-3 FATTY ACID AMINO ACID SALTS |
WO2019093708A1 (ko) * | 2017-11-08 | 2019-05-16 | 김승수 | 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법 |
KR102172036B1 (ko) * | 2017-11-08 | 2020-10-30 | 주식회사 오스테온 | 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법 |
CA3121055C (en) * | 2018-11-30 | 2024-04-16 | Evonik Operations Gmbh | Preparation comprising a dispersion of phospholipids and fatty acid salts |
WO2020225068A1 (en) | 2019-05-06 | 2020-11-12 | Evonik Operations Gmbh | Preparation for use in weight management comprising omega-3 fatty acid salts and basic amino acids |
US20220287345A1 (en) | 2019-08-08 | 2022-09-15 | Evonik Operations Gmbh | Solubility enhancement of poorly soluble actives |
US20220280388A1 (en) | 2019-08-08 | 2022-09-08 | Evonik Operations Gmbh | Method of preparing a solid dosage form and a binder |
JP2022543283A (ja) | 2019-08-08 | 2022-10-11 | エボニック オペレーションズ ゲーエムベーハー | 多価不飽和脂肪酸塩を製造するための下流処理 |
EP3804699A1 (en) | 2019-10-10 | 2021-04-14 | Evonik Operations GmbH | Method of preparing a solid dosage form and a binder |
MX2022001568A (es) | 2019-08-08 | 2022-03-02 | Evonik Operations Gmbh | Procedimiento de preparacion de una forma de dosificacion solida y un lubricante. |
AU2021213077A1 (en) * | 2020-01-30 | 2022-09-08 | Silicycle Inc. | Process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids |
US20230037453A1 (en) | 2020-04-01 | 2023-02-09 | Evonik Operations Gmbh | Preparation for use as vasorelaxant |
US20230149336A1 (en) | 2020-04-01 | 2023-05-18 | Evonik Operations Gmbh | Preparation for use as antioxidant |
DE102022003441A1 (de) | 2022-09-17 | 2024-03-28 | Jutta Ibrahim | Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7405325A (es) * | 1973-04-25 | 1974-10-29 | ||
HU209973B (en) * | 1988-03-09 | 1995-01-30 | Biorex Kutato Fejlesztoe Kft | Process for production of antiviral and immunstimular pharmaceutical composition |
GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
-
1993
- 1993-12-14 IT IT93MI002612A patent/IT1264987B1/it active IP Right Grant
-
1994
- 1994-11-28 AU AU12412/95A patent/AU1241295A/en not_active Abandoned
- 1994-11-28 JP JP7516492A patent/JPH09508619A/ja active Pending
- 1994-11-28 US US08/649,707 patent/US5750572A/en not_active Expired - Lifetime
- 1994-11-28 DE DE69409969T patent/DE69409969T2/de not_active Expired - Lifetime
- 1994-11-28 EP EP95903298A patent/EP0734373B1/en not_active Expired - Lifetime
- 1994-11-28 WO PCT/EP1994/003943 patent/WO1995016661A1/en active IP Right Grant
- 1994-11-28 ES ES95903298T patent/ES2117390T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1995016661A1 (en) | 1995-06-22 |
ITMI932612A0 (it) | 1993-12-14 |
IT1264987B1 (it) | 1996-10-17 |
US5750572A (en) | 1998-05-12 |
EP0734373B1 (en) | 1998-04-29 |
ITMI932612A1 (it) | 1995-06-14 |
JPH09508619A (ja) | 1997-09-02 |
AU1241295A (en) | 1995-07-03 |
EP0734373A1 (en) | 1996-10-02 |
DE69409969T2 (de) | 1998-12-10 |
DE69409969D1 (de) | 1998-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2117390T3 (es) | Sales de un acido graso poliinsaturado y formulaciones farmaceuticas que las contienen. | |
DE60000133D1 (de) | Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen | |
ID21473A (id) | Sediaan farmasi yang mengandung asam eikosapentanoat dan asam stearidonat | |
DE3875425T2 (de) | Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen. | |
ES2099022B1 (es) | Composiciones farmaceuticas que contienen las sales de acido s(+)-2-(4-isobutilfenil) propionico con aminoacidos basicos. | |
FI970298A (fi) | DHA:n käyttö farmaseuttisena koostumuksena | |
NO940288L (no) | Formuleringer inneholdende umettede fettsyrer | |
ES2149253T3 (es) | Medicamentos a base de acido docosahexaenoico como antiagregantes plaquetarios y contra las carencias cerebrales en acidos grasos esenciales y procedimientos de preparacion. | |
FI863976A0 (fi) | Terapeutisk komposition. | |
DE3862337D1 (de) | Pharmazeutische zubereitungen, die ester oder amide als wirkstoffe enthalten. | |
ES2093395T3 (es) | Esteres de acil carnitinas con alcoholes alifaticos de cadena larga y composiciones farmaceuticas que los contienen con actividad antibacteriana. | |
GB8812653D0 (en) | Pharmaceutical composition based on high concentration esters of docosahexaenoic acid | |
ES2196187T3 (es) | Conjugados peptidicos derivados de las hormonas timicas, su utilizacion a titulo de medicamento y composiciones que los contienen. | |
ES2069915T3 (es) | Dicarbonatos y uretanos de los acidos 4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracenocarboxilicos que tienen actividades terapeuticas. | |
ATE191341T1 (de) | Tabletten mit thioctsäure bestimmter korngrösse | |
ITRM930365A0 (it) | Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee. | |
ES2062529T3 (es) | Uso de alcoholes alifaticos, de c-20 a c-26, para la realizacion de un medicamento destinado al tratamiento de infecciones virales. | |
ES2084348T3 (es) | N-((4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracen-il)carbonil)aminoacidos utiles en la terapia de afecciones osteoarticulares. | |
ES2082390T3 (es) | Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias. | |
KR880010762A (ko) | 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers) | |
ES2163450T3 (es) | Utilizacion de benzidamina en el tratamiento de estados patologicos causados por tnf. | |
DE69423623T2 (de) | Aminosäureergänzung | |
SE8504191D0 (sv) | Acetyldicarnitine | |
Wenderoth | Aspects of the new eicosanoid-research.). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 734373 Country of ref document: ES |